Related Experiment Video

Updated: Apr 21, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

13.1K

Duodenal ferroportin is up-regulated in patients with chronic hepatitis C

Lanqing Ma1, Tong Zou2, Yuping Yuan1

  • 1Department of Digestive Diseases, The First Affiliated Hospital, Kunming Medical University, Kunming, Yunnan, China.

Plos One
|October 21, 2014
PubMed

Insights

Chronic hepatitis C (CHC) leads to iron overload by suppressing hepcidin, which increases duodenal ferroportin-1 (Fpn1) expression. Despite elevated iron, bacterial infection rates are not increased in CHC patients.

Area of Science:

  • Hepatology
  • Virology
  • Iron Metabolism

Background:

  • Hepatitis C virus (HCV) infection is a major cause of liver disease and mortality.
  • Chronic hepatitis C (CHC) is linked to altered iron homeostasis, often resulting in elevated serum iron and hepatic iron.
  • HCV infection suppresses hepcidin, a key regulator of iron balance, contributing to iron overload.

Purpose of the Study:

  • To investigate the protein levels of duodenal ferroportin-1 (Fpn1) in patients with CHC.
  • To determine the relationship between Fpn1 expression, hepcidin levels, and iron parameters in CHC patients.

Main Methods:

  • Quantification of duodenal Fpn1 protein levels.
  • Correlation analysis between Fpn1 expression, hepcidin mRNA levels, and serum iron parameters.

Main Results:

  • Duodenal Fpn1 protein expression was significantly upregulated in CHC patients.
  • Fpn1 expression showed a negative correlation with hepcidin mRNA levels.
  • Fpn1 expression positively correlated with serum iron parameters.

Conclusions:

  • Diminished hepcidin in CHC leads to increased duodenal Fpn1, causing iron dysregulation.
  • Elevated iron levels in CHC patients do not appear to increase bacterial infection rates.

More Related Videos

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.8K
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

13.1K

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
24
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
18
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
377
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
20
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
8.0K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.0K